This inventor holds 1 USPTO granted patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovations of Markus Isler
Introduction
Markus Isler is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work focuses on innovative solutions for treating various health conditions.
Latest Patents
Markus Isler holds a patent for Pyrrolidone carboxamides. This patent describes compounds of formula (I) where R can be a group of formula (a) or (b), R can be phenyl, heteroalkyl, aryloxy, alkoxy, alkanoyl, or —NRR, with specific meanings provided in the description and claims. These compounds are designed to inhibit the interaction of neuropeptide Y (NPY) with one of the neuropeptide receptor subtypes (NPY-Y5). They are particularly suitable for the prevention and treatment of arthritis, diabetes, and especially eating disorders and obesity. The compounds can be produced by known methods and converted into a galenic dosage form.
Career Highlights
Markus Isler is associated with Actelion Pharmaceuticals Ltd., where he has been instrumental in advancing pharmaceutical research and development. His innovative approach has led to the creation of valuable therapeutic agents that address critical health issues.
Collaborations
Throughout his career, Markus has collaborated with notable colleagues, including Kurt Hilpert and Matthias Steger. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Markus Isler's contributions to the field of pharmaceuticals through his patent on Pyrrolidone carboxamides exemplify his commitment to innovation and improving health outcomes. His work continues to influence the development of effective treatments for various medical conditions.